Beneficial effect of Flos magnoliae extract on multiple low dose streptozotocin-induced type 1 diabetes development and cytokine-induced β-cell damage

International Journal of Molecular Medicine

Volumn 22, Issue 4, 2008, Pages 481-488

  Kim, Eun Kyung ^a   Song, Mi Young ^a   Kim, In Seob ^b   Moon, Woo Sung ^a   Ryu, Do Gon ^b   So, Hong Seob ^a,c   Park, Raekil ^c   Park, Jin Woo ^a   Kwon, Kang Beom ^b,c   Park, Byung Hyun ^a  

^a Chonbuk National University   (South Korea)

^b Wonkwang University   (South Korea)

^c Wonkwang University   (South Korea)

Author keywords

Cell; Cytokine; Flos magnoliae extract; Nuclear factor B; Streptozotocin

Indexed keywords

FLOS MAGNOLIAE EXTRACT; GAMMA INTERFERON; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; PLANT EXTRACT; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOS MAGNOLIAE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HYPERGLYCEMIA; HYPOINSULINEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INHIBITION KINETICS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MAGNOLIACEAE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ANIMALS; CELL DEATH; CELL LINE; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DNA; FEMALE; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; MAGNOLIA; MALE; MICE; MICE, INBRED ICR; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 54049121776     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm_00000046     Document Type: Article

References (34)

1. Atkinson MA and Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331: 1428-1436, 1994.
2. Papaccio G: Insulitis and islet microvasculature in type 1 diabetes. Histol Histopathol 8: 751-759, 1993.
3. Scherbaum WA: Etiology and pathogenesis of type 1 diabetes. Horm Metab Res Suppl 26: 111-116, 1992.
4. Hohmeier HE, Tran VV, Chen G, Gasa R and Newgard CB: Inflammatory mechanisms in diabetes: lessons from the β-cell. Int J Obes Relat Metab Disord 27 (Suppl 3): 12-16, 2003.
5. Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT and Corbett JA: IL-1 produced and released endogenously within human islets inhibits β cell function. J Clin Invest 102: 516-526, 1998.
6. Cetkovic-Cvrlje M and Eizirik DL: TNF-α and IFN-γ potentiate the deleterious effects of IL-1β an mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6: 399-406, 1994.
7. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T and Taniguchi N: Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44: 733-738, 1995.
8. Stadler J, Billiar TR, Curran RD, Stuchr DJ, Ochoa JB and Simmons RL: Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 260: C910-C916, 1991.
9. Szkudelski T: The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 537-546, 2001.
10. 2 as an intermediate. J Biol Chem 266: 2112-2114, 1991.
11. Tsuji A and Sakurai H: Generation of nitric oxide from streptozotocin (STZ) in the presence of copper(II) plus ascorbate: implication for the development of STZ-induced diabetes. Biochem Biophys Res Commun 245: 11-16, 1998.
12. Kwon NS, Lee SH, Choi CS, Kho T and Lee HS: Nitric oxide generation from streptozotocin. FASEB J 8: 529-533, 1994.
13. Turk J, Corbett JA, Ramanadham S, Bohrer A and McDaniel ML: Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Commun 197: 1458-1464, 1993.
14. Papaccio G, Pisanti FA, Latronico MV, Ammendola E and Galdieri M: Multiple low-dose and single high-dose treatments with streptozotocin do not generate nitric oxide. J Cell Biochem 77: 82-91, 2000.
15. Elsner M, Guldbakke B, Tiedge M, Munday R and Lenzen S: Relative importance of transport and alkylation for pancreatic β-cell toxicity of streptozotocin. Diabetologia 43: 1528-1533, 2000.
16. Carlsson PO, Flodstrom M and Sandler S: Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice. Endocrinology 141: 2752-2757, 2000.
17. Lukic ML, Stosic-Grujicic S and Shahin A: Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev Immunol 6: 119-128, 1998.
18. Flodstrom M, Tyrberg B, Eizirik DL and Sandler S: Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 48: 706-713, 1999.
19. Giannoukakis N, Rudert WA, Trucco M and Robbins PD: Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an IκB repressor. J Biol Chem 275: 36509-36513, 2000.
20. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M and Eizirik DL: Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50: 2219-2224, 2001.
21. Kim EK, Kwon KB, Koo BS, Han MJ, Song MY, Song EK, Han MK, Park JW, Ryu DG and Park BH: Activation of peroxisome proliferator-activated receptor-γ protects pancreatic β-cells from cytokine-induced cytotoxicity via NFκB pathway. Int J Biochem Cell Biol 39: 1260-1275, 2007.
22. Mabley JG, Hasko G, Liaudet L, Soriano F, Southan GJ, Salzman AL and Szabo C: NFκB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J Endocrinol 173: 457-464, 2002.
23. Kobayashi S, Kimura I and Kimura M: Inhibitory effect of magnosalin derived from Flos magnoliae on tube formation of rat vascular endothelial cells during the angiogenic process. Biol Pharm Bull 19: 1304-1306, 1996.
24. Kimura M, Suzuki J, Yamada T, Yoshizaki M, Kikuchi T, Kadota S and Matsuda S: Anti-inflammatory effect of neolignans newly isolated from the crude drug 'Shin-i' (Flos Magnoliae). Planta. Med 291-293, 1985.
25. Moncada S, Palmer RM and Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
26. Kwon KB, Kim EK, Lim JG, Shin BC, Han SC, Song BK, Kim KS, Seo EA and Ryu DG: Protective effect of Coptidis Rhizoma on S-nitroso-N-acetylpenicillamine (SNAP)-induced apoptosis and necrosis in pancreatic RINm5F cells. Life Sci 76: 917-929, 2005.
27. Ho E, Chen G and Bray TM: α-phenyl-tert-butylnitrone (PBN) inhibits NFκB activation offering protection against chemically induced diabetes. Free Radic Biol Med 28: 604-614, 2000.
28. Kim EK, Kwon KB, Han MJ, Song MY, Lee JH, Lv N, Ka SO, Yeom SR, Kwon YD, Ryu DG, Kim KS, Park JW, Park R and Park BH: Coptidis rhizoma extract protects against cytokine-induced death of pancreatic β-cells through suppression of NF-κB activation. Exp Mol Med 39: 149-159, 2007.
29. Blackwell TS and Christman JW: The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 17: 3-9, 1997.
30. Richmond A: NF-κB, chemokine gene transcription and tumour growth. Nat Rev Immunol 2: 664-674, 2002.
31. Kim EK, Kwon KB, Han MJ, Song MY, Lee JH, Lv N, Choi KB, Ryu DG, Kim KS, Park JW and Park BH: Inhibitory effect of Artemisia capillaris extract on cytokine-induced nitric oxide formation and cytotoxicity of RINm5F cells. Int J Mol Med 19: 535-540, 2007.
32. Kim EK, Kwon KB, Song MY, Seo SW, Park SJ, Ka SO, Na L, Kim KA, Ryu DG, So HS, Park R, Park JW and Park BH: Genistein protects pancreatic B cells against cytokine-mediated toxicity. Mol Cell Endocrinol 278: 18-28, 2007.
33. Lv N, Song MY, Kim EK, Park JW, Kwon KB and Park BH: Guggulsterone, a plant sterol, inhibits NF-κB activation and protects pancreatic β cells from cytokine toxicity. Mol Cell Endocrinol 289: 49-59, 2008.
34. Oyadomari S, Takeda K, Takiguchi M, Gotoh T, Matsumoto M, Wada I, Akira S, Araki E and Mori M: Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci USA 98: 10845-10850, 2001.